Continuous Versus Intermittent Sciatic Block for Total Knee Arthroplasty

Phase 4

Completed

• Conditions: Total Knee Arthroplasty; Pain
• Interventions: Drug: Ropivacaine

• Registration Number: NCT01843153
• Lead Sponsor: Kreiskrankenhaus Dormagen

Brief Summary

The role of a sciatic block in addition to a femoral block remains controversial. The study addresses this topic by comparing a continuous block versus an injection on demand.

Detailed Description

Not available

Study Timeline

• Status Verified: 2013-04
• Study Start: 2013-04
• Study First Submitted: 2013-04-25
• Study First Submitted QC: 2013-04-29
• Study First Posted: 2013-04-30
• Primary Completion: 2014-10
• Study Completion: 2014-12
• Last Update Submitted: 2015-03-30
• Last Update Posted: 2015-03-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

• Patients scheduled for total knee arthroplasty

Exclusion Criteria

• failure to establish femoral and sciatic block
• insufficient analgesic effect of the block
• patient declines to participate

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
continuous	Ropivacaine	continuous ropivacaine infusion
intermittent	Ropivacaine	injection of ropivacaine on demand

Primary Outcome Measures

Name	Time	Method
pain score (VRS)	4 days

Secondary Outcome Measures

Name	Time	Method
frequency of injections into the sciatic catheter	4 days

Trial Locations

Locations (1)

KKH Dormagen; 🇩🇪 Dormagen, Germany